-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Neil Schneider, ASA, MAAA

Articles by Neil Schneider, ASA, MAAA

Third-Party Validation of Observed Savings From an Oncology Pathways Program

ByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MD

June 18th 2013

Latest Updated Articles

Third-Party Validation of Observed Savings From an Oncology Pathways Program
June 18th 2013

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

OneOncology Partners With OpenEvidence to Give Physicians Access Within Clinical Workflows

High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial

After Wild Ride, FDA Grants Accelerated Approval for Replimune’s RP1 Plus Nivolumab in Advanced Melanoma

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups